The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma.
Yousef A, Yousef M, Zeineddine M, More A, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine F, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally C, Kee B, Kopetz S, Goldstein D, Uppal A, White MG, Helmink B, Fournier K, Raghav K, Taggart M, Overman MJ, Shen JP.
Yousef A, et al. Among authors: more a.
medRxiv [Preprint]. 2023 Sep 11:2023.09.10.23295319. doi: 10.1101/2023.09.10.23295319.
medRxiv. 2023.
PMID: 37745596
Free PMC article.
Preprint.
RESULTS: A total of 1,338 patients with appendiceal adenocarcinoma were included, with a median age of 56.5 years. The majority of the patients had metastatic disease (80.7%). CEA was elevated in more than half of the patients tested (56%), while CA19-9 and C …
RESULTS: A total of 1,338 patients with appendiceal adenocarcinoma were included, with a median age of 56.5 years. The majorit …